Characterization of drug-related problems and evaluation of pharmacist interventions in the cardiovascular intensive care settings in Thailand

被引:2
作者
Wattanaruengchai, Phannita [1 ]
Kongwatcharapong, Junporn [1 ]
Nathisuwan, Surakit [2 ,3 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Pharm Dept, Bangkok, Thailand
[2] Mahidol Univ, Fac Pharm, Dept Pharm, Clin Pharm Div, Bangkok, Thailand
[3] Mahidol Univ, Fac Pharm, Dept Pharm, Clin Pharm Div, 447 Sri Ayutthaya Rd, Bangkok 10400, Thailand
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2023年 / 6卷 / 05期
关键词
cardiovascular intensive care unit; pharmacy service; Thailand; POSITION PAPER; UNIT; STATEMENT;
D O I
10.1002/jac5.1779
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
IntroductionData regarding drug-related problems (DRPs) and pharmacist's role in the cardiovascular intensive care units (CICU) from low- to middle-income countries (LMIC) are limited. ObjectiveThe study aimed to characterize the DRP and interventions provided by clinical pharmacists in the CICU settings. MethodA retrospective, cross-sectional study was conducted in patients admitted to CICU of a tertiary-care hospital in Thailand during January 2021 to March 2022 was performed. Data were collected from patient's medical records and pharmacy service records. DRPs were categorized according to the Pharmaceutical Care Network Europe classification. Two board-certified pharmacotherapy specialists, pharmacy residents, and trained clinical pharmacists staffed the units 5 days a week. The pharmacist team conducted a medication review and provided interventions to the cardiology team either verbally during the ward round or in writing, as appropriate. Pharmacist interventions were categorized into two groups including retrospective intervention (interventions made to resolve DRPs after an order was made) and prospective interventions (interventions made prior to ordering process). Outcome measures were (1) number of DRPs identified; (2) category of DRPs; (3) number interventions; and (4) acceptance rate of interventions by the medical team. ResultsAmong 576 patients admitted to the CICU, 345 DRPs were identified in 203 patients. The pharmacist team provided a total of 790 interventions including 345 retrospective interventions to resolve DRPs and 445 prospective interventions to guide medication use prior to the ordering process. The most frequent intervention was related to dosage adjustment, drug administration, adding drugs for existing conditions, and suggesting laboratory monitoring. The acceptance rate of the pharmacist intervention was 97.4%, most of which led to changes in drug therapy. ConclusionDRPs in CICU settings are common. Trained clinical pharmacists can effectively resolve DRPs and provide recommendations to improve quality of care through both clinical and distribution functions.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 28 条
  • [1] Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital
    Albayrak, Aslinur
    Basgut, Bilgen
    Bikmaz, Gulbin Aygencel
    Karahalil, Bensu
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [2] Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
    Amini, Maedeh
    Zayeri, Farid
    Salehi, Masoud
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [3] Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter?
    Anand, Shuchi
    Bradshaw, Christina
    Prabhakaran, Dorairaj
    [J]. BMC MEDICINE, 2020, 18 (01)
  • [4] Role of Clinical Pharmacists in Intensive Care Units
    Arredondo, Enrique
    Udeani, George
    Horseman, Michael
    Hintze, Trager D.
    Surani, Salim
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [5] Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model
    Brilli, RJ
    Spevetz, A
    Branson, RD
    Campbell, GM
    Cohen, H
    Dasta, JF
    Harvey, MA
    Kelley, MA
    Kelly, KM
    Rudis, MI
    St Andre, AC
    Stone, JR
    Teres, D
    Weled, BJ
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (10) : 2007 - 2019
  • [6] Do we need a pharmacist in the ICU?
    Chant, Clarence
    Dewhurst, Norman F.
    Friedrich, Jan O.
    [J]. INTENSIVE CARE MEDICINE, 2015, 41 (07) : 1314 - 1320
  • [7] Daniel W.W., 2013, Biostatistics A foundation for analysis in the health sciences, V10th
  • [8] Division of Non Communicable Disease Department of Disease Control Ministry of Public Health, 2019, NCD REP 2019 DIAB HY
  • [9] The Role of the Clinical Pharmacist in the Care of Patients With Cardiovascular Disease
    Dunn, Steven P.
    Birtcher, Kim K.
    Beavers, Craig J.
    Baker, William L.
    Brouse, Sara D.
    Page, Robert L., II
    Bittner, Vera
    Walsh, Mary Norine
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2129 - 2139
  • [10] Impact of clinical pharmacist intervention on therapy-related problems and costs in a cardiovascular unit of a tertiary healthcare facility in Amman, Jordan
    El-Refae, Huda G.
    Abuhamdah, Sawsan M. A.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (12) : 3013 - 3021